Article Versions Notes

Logozzi M, Angelini DF, Giuliani A, Mizzoni D, Di Raimo R, Maggi M, Gentilucci A, Marzio V, Salciccia S, Borsellino G, et al. Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study. Cancers. 2019; 11(10):1449. https://doi.org/10.3390/cancers11101449

Logozzi, Mariantonia, Daniela F. Angelini, Alessandro Giuliani, Davide Mizzoni, Rossella Di Raimo, Martina Maggi, Alessandro Gentilucci, Vittorio Marzio, Stefano Salciccia, Giovanna Borsellino, and et al. 2019. "Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study" Cancers 11, no. 10: 1449. https://doi.org/10.3390/cancers11101449

Logozzi, M., Angelini, D. F., Giuliani, A., Mizzoni, D., Di Raimo, R., Maggi, M., Gentilucci, A., Marzio, V., Salciccia, S., Borsellino, G., Battistini, L., Sciarra, A., & Fais, S. (2019). Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study. Cancers, 11(10), 1449. https://doi.org/10.3390/cancers11101449